Document Detail


SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia.
MedLine Citation:
PMID:  20685751     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Juvenile polyposis syndrome (JPS) and hereditary haemorrhagic telangiectasia (HHT) are autosomal dominant disorders with characteristic clinical phenotypes. Recently, reports of the combined syndrome of JPS and HHT have been described in individuals with mutations in the SMAD4 gene, whose product-SMAD4-is a critical intracellular effector in the signalling pathway of transforming growth factor beta (TGFbeta). This report describes a 24-year-old man who presented to the Respiratory Institute after colectomy for JPS with a SMAD4 mutation and who was subsequently diagnosed to have HHT with asymptomatic cerebral and pulmonary arteriovenous malformations (AVMs). Patients with JPS due to a SMAD4 mutation should be screened for the vascular lesions associated with HHT, especially occult AVMs in visceral organs, which may potentially present catastrophically with serious medical consequences.
Authors:
Nithya K Iyer; Carol A Burke; Brandie H Leach; Joseph G Parambil
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Thorax     Volume:  65     ISSN:  1468-3296     ISO Abbreviation:  Thorax     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-05     Completed Date:  2010-09-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  England    
Other Details:
Languages:  eng     Pagination:  745-6     Citation Subset:  IM    
Affiliation:
Department of Pulmonary & Critical Care Medicine, Respiratory Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenomatous Polyposis Coli / genetics*
Arteriovenous Malformations / radiography
Humans
Intracranial Arteriovenous Malformations / diagnosis
Male
Mutation*
Pulmonary Artery / abnormalities
Pulmonary Veins / abnormalities
Smad4 Protein / genetics*
Telangiectasia, Hereditary Hemorrhagic / genetics*,  radiography
Tomography, X-Ray Computed
Young Adult
Chemical
Reg. No./Substance:
0/SMAD4 protein, human; 0/Smad4 Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pu...
Next Document:  The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic.